Vaccibody As Stock Last Dividend Paid
Vaccibody As fundamentals help investors to digest information that contributes to Vaccibody's financial success or failures. It also enables traders to predict the movement of Vaccibody Stock. The fundamental analysis module provides a way to measure Vaccibody's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaccibody stock.
Vaccibody |
Vaccibody As Company Last Dividend Paid Analysis
Vaccibody's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
CompetitionBased on the recorded statements, Vaccibody As has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Norway stocks average (which is currently at 0.0).
Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
All Next | Launch Module |
Vaccibody Fundamentals
Return On Equity | -0.23 | |||
Return On Asset | -0.15 | |||
Operating Margin | (77.18) % | |||
Current Valuation | 32.03 M | |||
Shares Outstanding | 38.55 M | |||
Shares Owned By Insiders | 3.45 % | |||
Shares Owned By Institutions | 49.84 % | |||
Number Of Shares Shorted | 159.22 K | |||
Price To Earning | 12.63 X | |||
Price To Book | 0.36 X | |||
Price To Sales | 2.31 X | |||
Revenue | 44.7 M | |||
Gross Profit | 44.7 M | |||
EBITDA | 869 K | |||
Net Income | 5.32 M | |||
Cash And Equivalents | 192.33 M | |||
Cash Per Share | 5.17 X | |||
Total Debt | 8.77 M | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 18.60 X | |||
Book Value Per Share | 5.64 X | |||
Cash Flow From Operations | (14.43 M) | |||
Short Ratio | 0.08 X | |||
Earnings Per Share | (1.59) X | |||
Target Price | 9.31 | |||
Number Of Employees | 33 | |||
Beta | -0.39 | |||
Market Capitalization | 192.73 M | |||
Total Asset | 270.2 M | |||
Retained Earnings | (103.24 M) | |||
Working Capital | 200.8 M | |||
Z Score | 13.71 | |||
Net Asset | 270.2 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in Vaccibody Stock
If you are still planning to invest in Vaccibody As check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccibody's history and understand the potential risks before investing.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |